Lidocan IV Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Lidocan IV
A
- Aczone (dapsone topical)
- Adenocaine PF (adenosine / lidocaine / magnesium sulfate)
- adenosine / lidocaine / magnesium sulfate
- AgonEaze (lidocaine / prilocaine topical)
- Alkabel-SR (atropine / hyoscyamine / phenobarbital / scopolamine)
- aminophylline / ephedrine / guaifenesin / phenobarbital
- aminophylline / ephedrine / phenobarbital / potassium iodide
- aminosalicylic acid
- amyl nitrite
- amyl nitrite/sodium nitrite/sodium thiosulfate
- Anestacaine (lidocaine)
- Anodyne LPT (lidocaine / prilocaine topical)
- Antispas (atropine / hyoscyamine / phenobarbital / scopolamine)
- Antispasmodic (atropine / hyoscyamine / phenobarbital / scopolamine)
- Antrocol (atropine / phenobarbital)
- Arakoda (tafenoquine)
- Aralen (chloroquine)
- Aralen Hydrochloride (chloroquine)
- Aralen Phosphate (chloroquine)
- Articadent (articaine / epinephrine)
- articaine / epinephrine
- atropine / hyoscyamine / phenobarbital / scopolamine
- atropine / phenobarbital
- Azo Gantanol (phenazopyridine / sulfamethoxazole)
- Azo Gantrisin (phenazopyridine / sulfisoxazole)
- Azo Urinary Pain Relief (phenazopyridine)
- Azo-Gesic (phenazopyridine)
- Azo-Septic (phenazopyridine)
- Azo-Standard (phenazopyridine)
- Azo-Truxazole (phenazopyridine / sulfisoxazole)
- Azulfidine (sulfasalazine)
- Azulfidine EN-tabs (sulfasalazine)
More about Lidocan IV (lidocaine topical)
- Check interactions
- Compare alternatives
- Latest FDA alerts (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.